281 related articles for article (PubMed ID: 31866467)
1. Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis.
Liu W; Wang W; Wang X; Xu C; Zhang N; Di W
Cancer Lett; 2020 Mar; 472():59-69. PubMed ID: 31866467
[TBL] [Abstract][Full Text] [Related]
2. Chemokine CCL20 promotes the paclitaxel resistance of CD44
Chen M; Su J; Feng C; Liu Y; Zhao L; Tian Y
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278466
[TBL] [Abstract][Full Text] [Related]
3. CCL20/CCR6 axis mediates macrophages to promote proliferation and migration of ESCs by blocking autophagic flux in endometriosis.
Tan J; Xu T; Gou Y; Wang H; Liang Z; Cao Y; Wang H; Yu Y; Jiao N; Zhang Z
Stem Cell Res Ther; 2022 Jul; 13(1):294. PubMed ID: 35841069
[TBL] [Abstract][Full Text] [Related]
4. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.
Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110
[TBL] [Abstract][Full Text] [Related]
5. CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling.
Xie T; Fu DJ; Li ZM; Lv DJ; Song XL; Yu YZ; Wang C; Li KJ; Zhai B; Wu J; Feng NH; Zhao SC
Mol Cancer; 2022 Sep; 21(1):173. PubMed ID: 36045408
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated macrophage-derived CCL20 enhances the growth and metastasis of pancreatic cancer.
Liu B; Jia Y; Ma J; Wu S; Jiang H; Cao Y; Sun X; Yin X; Yan S; Shang M; Mao A
Acta Biochim Biophys Sin (Shanghai); 2016 Dec; 48(12):1067-1074. PubMed ID: 27797715
[TBL] [Abstract][Full Text] [Related]
7. CrkL meditates CCL20/CCR6-induced EMT in gastric cancer.
Han G; Wu D; Yang Y; Li Z; Zhang J; Li C
Cytokine; 2015 Dec; 76(2):163-169. PubMed ID: 26044596
[TBL] [Abstract][Full Text] [Related]
8. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
9. The Role of CCL20-CCR6 Axis in Ovarian Cancer Metastasis.
Liu W; Wang W; Zhang N; Di W
Onco Targets Ther; 2020; 13():12739-12750. PubMed ID: 33335408
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma.
Ito M; Teshima K; Ikeda S; Kitadate A; Watanabe A; Nara M; Yamashita J; Ohshima K; Sawada K; Tagawa H
Blood; 2014 Mar; 123(10):1499-511. PubMed ID: 24385540
[TBL] [Abstract][Full Text] [Related]
11. The key role of astrocyte elevated gene-1 in CCR6-induced EMT in cervical cancer.
Zhang J; Zhu D; Lv Q; Yi Y; Li F; Zhang W
Tumour Biol; 2015 Dec; 36(12):9763-7. PubMed ID: 26156805
[TBL] [Abstract][Full Text] [Related]
12. The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma.
Du D; Liu Y; Qian H; Zhang B; Tang X; Zhang T; Liu W
Int J Mol Sci; 2014 Apr; 15(4):6441-52. PubMed ID: 24743888
[TBL] [Abstract][Full Text] [Related]
13. Atezolizumab and Bevacizumab Attenuate Cisplatin Resistant Ovarian Cancer Cells Progression Synergistically via Suppressing Epithelial-Mesenchymal Transition.
Zhang L; Chen Y; Li F; Bao L; Liu W
Front Immunol; 2019; 10():867. PubMed ID: 31105696
[TBL] [Abstract][Full Text] [Related]
14. CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production.
Zeng W; Chang H; Ma M; Li Y
Exp Mol Pathol; 2014 Aug; 97(1):184-90. PubMed ID: 24984269
[TBL] [Abstract][Full Text] [Related]
15. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S
Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142
[TBL] [Abstract][Full Text] [Related]
16. CCL20 Expression by Tumor-Associated Macrophages Predicts Progression of Human Primary Cutaneous Melanoma.
Samaniego R; Gutiérrez-González A; Gutiérrez-Seijo A; Sánchez-Gregorio S; García-Giménez J; Mercader E; Márquez-Rodas I; Avilés JA; Relloso M; Sánchez-Mateos P
Cancer Immunol Res; 2018 Mar; 6(3):267-275. PubMed ID: 29362221
[TBL] [Abstract][Full Text] [Related]
17. The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients.
Zhang CY; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
Biomed Pharmacother; 2015 Feb; 69():242-8. PubMed ID: 25661365
[TBL] [Abstract][Full Text] [Related]
18. Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases.
Rubie C; Frick VO; Ghadjar P; Wagner M; Justinger C; Graeber S; Sperling J; Kollmar O; Schilling MK
World J Gastroenterol; 2011 Jul; 17(26):3109-16. PubMed ID: 21912453
[TBL] [Abstract][Full Text] [Related]
19. CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway.
Lu E; Su J; Zhou Y; Zhang C; Wang Y
Biomed Pharmacother; 2017 Jan; 85():486-492. PubMed ID: 27916417
[TBL] [Abstract][Full Text] [Related]
20. The CCL20-CCR6 Axis in Cancer Progression.
Kadomoto S; Izumi K; Mizokami A
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
